Compounded Semaglutide Risks: What the FDA Wants You to Know

The meteoric rise of GLP-1 medications like Ozempic and Wegovy created a demand that manufacturers simply could not meet. This shortage opened the door for compounded versions of semaglutide—custom-made alternatives often sold at a fraction of the cost. While they may seem like a convenient fix, the U.S. Food and Drug Administration (FDA) has issued serious warnings about the safety, purity, and effectiveness of these unauthorized products.

Understanding the Difference: Compounded vs. FDA-Approved

To understand the risks, you first need to understand what you are buying. When you purchase brand-name Ozempic or Wegovy (manufactured by Novo Nordisk), you are buying an FDA-approved drug. This means the agency has rigorously reviewed its manufacturing process, safety data, and clinical efficacy.

Compounded drugs are different. Compounding is the practice of combining, mixing, or altering ingredients to create a medication tailored to the needs of an individual patient. While compounding pharmacies serve a vital role in healthcare—such as creating liquid versions of pills for patients who cannot swallow—compounded semaglutide is not FDA-approved.

The FDA does not verify the safety or effectiveness of compounded drugs. When you inject a compounded version of semaglutide, you are relying entirely on the quality controls of that specific pharmacy, rather than the strict federal standards applied to major pharmaceutical manufacturers.

The Danger of "Semaglutide Salts"

One of the most specific and urgent warnings from the FDA concerns the ingredients used in these compounded formulas.

The active ingredient in FDA-approved Wegovy and Ozempic is semaglutide base. However, the FDA has identified that some compounders are using salt forms of the drug, specifically:

• Semaglutide sodium
• Semaglutide acetate

These salt forms are distinct chemical substances. They are not the same as the base form found in the approved drugs. The FDA has stated clearly that they are not aware of any basis for compounding using the salt forms that would meet the requirements of the Federal Food, Drug, and Cosmetic Act.

Using the salt form changes how the drug behaves in the body. It has not been shown to be safe or effective for weight loss or diabetes management. If your medication lists “semaglutide sodium” or “acetate” as an ingredient, you are taking an unverified chemical substance.

Dosing Errors and Hospitalizations

Another major risk factor involves the delivery method. Brand-name Ozempic and Wegovy come in pre-filled injector pens. These devices are engineered to deliver the exact prescribed dose with a simple click.

Compounded semaglutide, typically sold in multi-dose glass vials, requires the patient to draw up the medication using a syringe. This introduces a high margin for human error. The FDA has received multiple adverse event reports regarding patients who accidentally administered 5 to 10 times the intended dose.

Why these errors happen:

• Confusing Units: Prescriptions may be written in milligrams (mg), but the syringe measures in units or milliliters (ml). Patients often struggle to convert the math correctly.
• Concentration Variance: Different compounding pharmacies mix the drug at different strengths. 0.5 ml from one pharmacy might contain 1 mg of drug, while 0.5 ml from another contains 2.5 mg.

The consequences of an overdose are severe. Reports to the FDA describe patients suffering from intractable vomiting, severe dehydration, and hypoglycemia (dangerously low blood sugar), often requiring emergency hospitalization to stabilize.

Lack of Sterility and Quality Assurance

Because compounded drugs do not undergo the FDA’s pre-market review, there is a higher risk of contamination. Injectable medications must be sterile. If a compounding pharmacy does not maintain strict sterile environments, the vial can become contaminated with bacteria or fungi.

Injecting a contaminated substance can lead to serious infections at the injection site or even systemic blood infections (sepsis).

While there are two types of compounding facilities—503A (traditional community pharmacies) and 503B (outsourcing facilities with stricter standards)—consumers purchasing online often have no way of knowing where their medication originated. Many “telehealth” weight loss mills act as middlemen, shipping vials from undisclosed locations that may not adhere to state or federal safety regulations.

Navigating the Shortage Safely

The legality of compounding copies of commercially available drugs usually hinges on the FDA’s drug shortage list. When a drug is officially in shortage, restrictions on compounding usually loosen. However, this does not remove the safety risks.

If you are currently using or considering compounded semaglutide, take these steps to protect your health:

1. Check the Ingredients: Ask specifically if the medication is made with “semaglutide base.” If the provider cannot confirm this or admits to using salts, do not take it.
2. Verify the Source: Ensure the medication comes from a state-licensed pharmacy in the United States. Avoid buying from unlicensed websites that do not require a prescription.
3. Consult Your Doctor: Do not obtain these drugs without the oversight of a healthcare provider who can monitor your blood work and reaction to the medication.
4. Verify the Dose: If you must use a syringe, have a pharmacist or nurse teach you exactly how to draw up the dose. Do not guess based on markings you do not understand.

Frequently Asked Questions

Is compounded semaglutide illegal? It is generally complicated. When a drug is on the FDA’s shortage list, compounding pharmacies are typically permitted to make versions of it to meet demand. However, they must still adhere to specific rules regarding ingredients. Making copies of a drug that is not in shortage is generally illegal.

Does the FDA approve any generic Ozempic? No. As of late 2024, there are no FDA-approved generic versions of Ozempic or Wegovy. Novo Nordisk holds the patent for semaglutide, meaning any “generic” you see advertised is actually an unauthorized compounded version.

What should I do if I have a bad reaction to a compounded drug? Seek medical attention immediately. Afterward, you or your doctor should report the reaction to the FDA’s MedWatch program. This helps the agency track dangerous batches and take action against unsafe compounders.

Why is the compounded version so much cheaper? Compounding pharmacies do not have the overhead of clinical trials, massive marketing campaigns, or patent protection costs. However, the lower price reflects the lack of regulatory testing and safety assurance that comes with the brand-name product.